Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Germany-based network of urban hospitals, Kliniken der Stadt Koln, has deployed Luminex's xTAG Gastrointestinal Pathogen Panel (GPP) as a first-line screen for patients with E coli infection.
Subscribe to our email newsletter
Luminex’s xTAG GPP detects hemolytic-uremic syndrome (HUS) causing Shiga-like toxin producing E. coli strain (STEC), besides detecting common disease-causing gastrointestinal pathogens, including viruses, bacteria and parasites, such as E. coli, Campylobacter, Salmonella and C. difficile.
xMAP multiplex solutions include a technology platform that delivers bioassay results to markets as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including genomic and proteomic research markets.
Frauke Mattner of Kliniken der Stadt Institute of Pathology and Institute for Hygiene said the ability of xTAG GPP to detect not only several different types of E. coli, but also the presence of the Stx-2 gene, a marker of this more severe STEC strain, is allowing rapid identification of patients who are suffering from an infection of this strain.